← Back to headlines
Immunic to Host Virtual R&D Day for Relapsing Multiple Sclerosis Research
The biopharmaceutical company will present clinical data and development updates for its relapsing multiple sclerosis pipeline on September 9, 2026.
2 Sept, 11:13 — 2 Sept, 11:13
Sources
Showing 1 of 1 sources
